After nearly a decade of development and millions of dollars invested, Arrow International (Reading, Pennsylvania), after nearly a decade of development and millions invested, said in early April that it will discontinue its LionHeart left ventricular assist system (LVAS) program and focus its resources on CoreAide continuous flow, ventricular assist device (VAD).